PortfoliosLab logo

Amphastar Pharmaceuticals, Inc. (AMPH)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS03209R1032
CUSIP03209R103
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$28.69
Year Range$19.48 - $42.29
EMA (50)$29.44
EMA (200)$29.58
Average Volume$230.67K
Market Capitalization$1.39B

AMPHShare Price Chart


Loading data...

AMPHPerformance

The chart shows the growth of $10,000 invested in Amphastar Pharmaceuticals, Inc. in Jun 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $33,349 for a total return of roughly 233.49%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-21.43%
-2.57%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMPHCompare to other instruments

Search for stocks, ETFs, and funds to compare with AMPH

AMPHReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-1.55%4.33%
6M-19.35%-0.78%
YTD25.29%-15.53%
1Y39.48%-14.36%
5Y9.79%9.13%
10Y15.38%8.93%

AMPHMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-0.86%20.01%29.56%-1.20%4.71%-6.33%7.47%-20.83%-5.07%9.96%-5.57%
2021-9.60%-3.58%4.51%-5.02%8.74%6.55%3.92%-6.16%-3.31%-1.74%4.71%19.07%
2020-1.97%-18.61%-3.57%14.22%9.97%20.49%-10.86%1.80%-8.00%4.48%-9.34%13.23%
201914.37%9.18%-17.79%5.68%-10.84%9.66%-4.55%11.46%-11.71%-2.60%1.01%-1.13%
2018-3.12%-1.50%2.12%1.81%-17.23%-3.42%14.35%8.77%1.37%-6.70%21.00%-8.38%
2017-14.50%-1.78%-6.27%4.14%13.05%4.63%-3.25%-7.35%11.62%1.12%8.41%-1.79%
2016-15.32%-12.61%13.96%2.50%27.89%2.48%0.37%17.43%-0.16%-4.38%11.74%-9.13%
20154.48%15.42%6.86%-3.34%6.09%14.60%-7.51%-20.85%-9.17%1.28%29.65%-7.30%
201414.40%-11.29%36.15%-3.64%-12.96%2.86%11.31%

AMPHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Amphastar Pharmaceuticals, Inc. Sharpe ratio is 0.77. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
0.77
-0.60
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMPHDividend History


Amphastar Pharmaceuticals, Inc. doesn't pay dividends

AMPHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-31.00%
-16.06%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMPHWorst Drawdowns

The table below shows the maximum drawdowns of the Amphastar Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amphastar Pharmaceuticals, Inc. is 49.92%, recorded on Mar 20, 2020. It took 456 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.92%Mar 4, 2019266Mar 20, 2020456Jan 10, 2022722
-43.39%Nov 18, 201678Mar 14, 2017420Nov 9, 2018498
-42.11%Jun 26, 2015170Feb 29, 2016115Aug 11, 2016285
-35.49%Apr 14, 2022144Nov 8, 2022
-20.08%Sep 21, 201632Nov 3, 201610Nov 17, 201642
-18.81%Sep 11, 201444Nov 11, 201418Dec 8, 201462
-17.24%Jun 30, 20148Jul 10, 201432Aug 25, 201440
-15.42%Dec 4, 201814Dec 24, 201819Jan 23, 201933
-12.25%Aug 24, 201614Sep 13, 20165Sep 20, 201619
-11.5%Jan 8, 20156Jan 15, 201513Feb 4, 201519

AMPHVolatility Chart

Current Amphastar Pharmaceuticals, Inc. volatility is 11.09%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%JuneJulyAugustSeptemberOctoberNovember
11.09%
12.31%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)